I13004—Immunology/ Rheumatology

Contact:

Mentor/Principal InvestigatorRobert P. Kimberly, M.D. Professor  Mailing address: SHEL 176, 1530 3RD AVENUE S, BIRMINGHAM AL 35294-2182  Telephone: (205) 934-0245  E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.


Postdoctoral Position Available:  Autoimmunity and Immunologic Mechanisms

Research opportunities are available in cellular and molecular immunology; genetic organization and variation of immune response genes; structure and function of immunoglobulins; transgenic models of immune function; host responses to infectious agents; transplantation immunology; and neuroimmunology.

The primary emphasis of the program is the unraveling of pathogenetic mechanisms operative in diseases of immune etiology. Mentors involved in both their own research programs and in the care of patients with autoimmune and immune-mediate inflammatory diseases provide an opportunity for translational work between basic and applied immunology. Opportunities in human biology and disease are available in autoimmune and immune-mediated inflammatory diseases, immunodeficiencies, malignant diseases, host-defense defense including vaccine development, and transplantation immunology. Outstanding investigator-based and core-based facilities are available. Resources include state-of-the-art high-speed flow cytometry, high resolution imaging (confocal, FRET, standard and cryo-electron microscopy), nucleic acid and protein sequencing, hybridoma/phage display antibody production, and transgenic/ES cell mouse facilities.

Postdoctoral trainees with an M.D., Ph.D., or equivalent terminal degree are selected on the basis of prior academic and research performance, letters of recommendation, and personal interviews. Successful candidates will demonstrate strong commitment to a research and teaching career in academic immunology. For further information, please contact Dr. Robert Kimberly, E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. .

UAB News

  • Bluesman Keb’ Mo’ will take the stage first at 7 p.m., with alternative hip-hop  rockers G. Love & Special Sauce performing the second set.Keb' Mo'The University of Alabama at Birmingham’s Alys Stephens Performing Arts Center will present Keb’ Mo’ and G. Love & Special Sauce on Tuesday, Aug. 26. The two bands will perform as co-headliners; each will perform a separate set, with Keb’ Mo’ first. The show is set for 7 p.m., in the ASC,...

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...

UAB Research News

  • The Quad Rider makes it easy to shift gears and brake, enabling people with poor grip-control to safely cycle.The University of Alabama at Birmingham and the Lakeshore Foundation are partnering with InvoTek, Inc., to create a gear and braking device that helps people with disabilities who have limited or no use of their hands operate a handcycle safely. InvoTek, a research and development company in Alma, Arkansas, has received a $175,000 Phase I Small Business Innovation...

  • New drugs to slow or even prevent Parkinson’s could be in human studies as early as 2015.Written by Matt Windsor An enzyme closely associated with genetic forms of Parkinson’s disease appears to play a larger role in its progression than previously thought, say investigators at the University of Alabama at Birmingham. The new research offers encouraging evidence that drugs to block this enzyme, known as leucine-rich repeat kinase 2 or LRRK2, could slow — or even...